Skip to content

Functional Medicine Optimal Lab Ranges: What the Charts Get Right and Wrong

Oak
A lab analyzer column of amber fluid with a wide glowing blue band and a narrower gold band nested inside it.

A functional medicine optimal lab ranges chart is a table of narrower bands drawn inside the standard laboratory reference interval. TSH 1.0–2.0 mIU/L instead of 0.45–4.5. Ferritin 50–150 ng/mL instead of 15–400. Fasting glucose 75–86 mg/dL instead of 70–99. The narrowing is usually reasonable in direction and poorly documented in origin. Most published charts cite no derivation cohort, no outcome, and no assay platform. Our view is that you should treat these charts as weak priors and spend your effort on something with a real statistical foundation: your own reference interval, computed from repeated measurements of yourself.

What a population reference interval represents

A standard reference interval is the central 95% of results from a reference population the lab deemed healthy. It is a description of a crowd. It carries two consequences that people rarely internalize.

First, 5% of healthy people fall outside by construction. On a 40-analyte comprehensive metabolic panel plus CBC, the chance of at least one out-of-range flag in a perfectly healthy person is 1 − 0.95^40 ≈ 87%. A flagged value is a prompt to look. The flag alone is not a finding.

Second, the interval is assay-specific. Ferritin, vitamin D, testosterone, and thyroid antibody assays differ measurably between platforms. A Roche Cobas result and an Abbott Architect result for the same tube are not interchangeable at the precision a 50–150 ng/mL “optimal” band implies. Any chart that lists a number without a platform is discarding that information.

Why an optimal range chart is a weak prior

The charts are not wrong in spirit. Risk for many analytes is monotone across the reference interval, so the middle of the interval often does carry different expected outcomes than the edge. The problem is provenance. A cut point that is worth acting on comes from a cohort, an outcome, and a validation step in an independent sample. That path is long and most candidate markers fail somewhere along it.1

Compare that with a decision limit built deliberately. Cardiac troponin does not use a 95% healthy interval at all. Its threshold is the 99th percentile of a reference population. That choice reflects an asymmetric clinical question and a specified assay imprecision at that concentration.2 A defensible cut point states the population, the percentile, and the analytical performance requirement. Optimal range charts almost never supply any of the three.

Panels assembled from discovery work face the same burden. Blood transcriptome scores for heart failure recovery potential, for example, are defined against a specific outcome in a specific patient group before anyone quotes a number.3

Your own baseline beats any chart

The statistic that settles this is the index of individuality. Let CV_A be analytical imprecision, CV_I within-person biological variation, and CV_G between-person variation. Then:

II = sqrt(CV_A^2 + CV_I^2) / CV_G

When II is below roughly 0.6, each person occupies a narrow slice of the population distribution. A result can sit comfortably inside the population interval while being far from that individual’s own set point. Most analytes worth tracking behave this way. TSH, ferritin, creatinine, calcium, and serum sodium all have within-person variation much smaller than between-person variation. Immunological markers show the same pattern, and their measured biological variation is what sets the achievable quality goals for the assays themselves.4

The practical translation: for low-II analytes, the population reference interval is close to useless as a personal alarm. Your own repeated measurements are the reference.

Computing a personal reference interval

You need repeated measurements under matched conditions. Same fasting state, same approximate time of day, same lab and platform where possible. Five results gives a rough interval, ten gives something you can lean on.

Pull your results into one table. If your lab exposes FHIR, the Observation resources carry LOINC codes and units and are the cleanest source. Otherwise transcribe from PDFs and keep the units column accurate.

import pandas as pd, numpy as np

df = pd.read_csv("labs.csv", parse_dates=["collected"])
# columns: collected, loinc, analyte, value, unit, lab, platform, fasting

def personal_interval(s, z=1.96):
    s = s.astype(float)
    med, mad = s.median(), (s - s.median()).abs().median()
    keep = s[(s - med).abs() <= 3 * 1.4826 * mad]   # drop gross outliers
    m, sd = keep.mean(), keep.std(ddof=1)
    cv_i = sd / m
    return dict(n=len(keep), mean=m, sd=sd, cv_total=cv_i,
                lo=m - z*sd, hi=m + z*sd)

out = (df[df.fasting]
       .groupby(["analyte", "platform"])["value"]
       .apply(personal_interval)
       .apply(pd.Series))

Two cautions. The sd you compute mixes biological and analytical variation, so cv_total is sqrt(CV_A^2 + CV_I^2). The result is not CV_I alone. And grouping by platform matters. If your lab switched analyzers mid-series, treat the segments separately rather than pooling them.

Deciding whether a change is real

A second measurement that differs from the first is often noise. The reference change value tells you how large a difference must be before it exceeds analytical and biological variation:

RCV = 2**0.5 * z * sqrt(CV_A**2 + CV_I**2)     # z = 1.96 for 95%, two-sided

Plug in the cv_total you just computed. For an analyte with combined CV around 15%, such as ferritin, RCV is roughly 42%. A move from 80 to 100 ng/mL is inside the noise. A move from 80 to 130 is not. For sodium, with combined CV near 1%, a 3 mmol/L shift is already large.

This single calculation removes most of the false signal that optimal range charts generate. It also tells you how often testing is useful. If you cannot plausibly move an analyte by more than its RCV in three months, testing quarterly buys you nothing.

Preanalytical variation you must control

Before blaming physiology, rule out collection artifacts. Standing for ten minutes before a draw concentrates plasma proteins and everything bound to them by several percent. A prolonged tourniquet does the same locally. Serum iron and cortisol have strong diurnal swings and are not comparable across different draw times. Hemolysis raises potassium and LDH. Recent strenuous exercise raises CK, AST, and white cell counts for days.

Record fasting status, time of day, and days since hard exercise alongside every result. Without those columns your longitudinal series is not analyzable.

A chart format we would use

Replace the two-column “standard vs optimal” table with six columns per analyte.

  • LOINC code
  • platform
  • your n
  • your personal mean
  • your personal 95% interval
  • the RCV

Add a seventh column for a guideline decision limit where one genuinely exists, such as the troponin 99th percentile.2 Leave it blank otherwise rather than filling it with a consensus number of unknown origin.

Interpretation of any out-of-range result belongs with a clinician who can see the rest of your history. The analysis above tells you whether a change is real. It does not tell you what caused it or what to do about it.

Questions people also ask

Are functional medicine optimal ranges evidence-based? Some overlap with published risk gradients and some are consensus without a cited derivation. Treat an unsourced number as a hypothesis. Check whether the chart names a cohort, an outcome, and an assay platform.

How many tests do I need for a personal reference interval? Five under matched conditions gives a usable estimate, and ten or more gives a reasonably stable one. Below five, your standard deviation is dominated by sampling error.

Why do my results shift when I change labs? Assays are calibrated differently and reference intervals are platform-specific. Keep a platform column and analyze segments separately rather than pooling across a switch.

What is the index of individuality for? It tells you whether population reference intervals can detect a meaningful change in you. Low values mean your personal baseline is the better comparator, which is true for most analytes people track.4

Footnotes

  1. Nader Rifai, Michael A Gillette, Steven A Carr. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nature Biotechnology, 2006. https://doi.org/10.1038/nbt1235 ↩

  2. NACB WRITING GROUP MEMBERS, David A. Morrow, Christopher P. Cannon, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes. Circulation, 2007. https://doi.org/10.1161/circulationaha.107.182882 ↩ ↩2

  3. Mario C Deng. A Peripheral Blood Transcriptome Biomarker Test to Diagnose Functional Recovery Potential in Advanced Heart Failure. Biomarkers in Medicine, 2018. https://doi.org/10.2217/bmm-2018-0097 ↩

  4. Najib Aziz, Roger Detels, Joshua J. Quint, et al. Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests. BMC Immunology, 2019. https://doi.org/10.1186/s12865-019-0313-0 ↩ ↩2

Pothos builds longitudinal molecular profiles of individuals: whole-genome sequencing, single-cell RNA sequencing, and plasma proteomics, delivered as a detailed report, every data file, and stored cells. Build your profile.